C. Jillian Tsai, Lead of Palliative Radiotherapy and Oligometastases Program (PROP) at Princess Margaret Cancer Centre, posted on X:
“Congrats to Matthew McMillan from Memorial Sloan Kettering Cancer Center, on presenting the secondary analysis of CURB trial, highlighting the importance of tumor volume burden in prognosis.”
More from C. Jillian Tsai on OncoDaily.